(PGNX, MAKO, SKX) CRWENewswire Stocks In Action from is sales revenue liability or asset Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Good Tuesday Morning, Its August 9th, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. Progenics Pharmaceuticals Incorporated - symbol PGNX - reported Net income for the second quarter 2011 of $55.5 million compared to a net loss of $15.2 million in the same period the prior year. Second quarter U.S. sales of Progenics’ RELISTOR increased 99% over first quarter and 50% over prior year quarter. MAKO Surgical Corporation - symbol MAKO - posted Second quarter 2011 revenue of $18.6 mill
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)